A PRELIMINARY STUDY TO DETERMINE THE EFFECT OF ESOMEPRAZOLE MAGNESIUM (NEXIUM) ON STOMACH ACIDITY

Main Article Content

Dania Mustafa Ghulam
Dalal Abdulfattah Sukaik
Rahmah Ahmed Alsaeed
Haneen Hamad Alrefai
Nawal Saeed Hassan Alkhaldi
Sarah Ali Alfaraj

Keywords

esomeprazole magnesium, Nexium, stomach acidity, gastroesophageal reflux disease (GERD), pH monitoring

Abstract

This preliminary study aimed to determine the effect of esomeprazole magnesium (Nexium) on stomach acidity. The study utilized a randomized controlled trial design with a sample size of 50 participants who were diagnosed with gastroesophageal reflux disease (GERD). The participants were divided into two groups: one group received esomeprazole magnesium for a period of four weeks, while the other group received placebo. Stomach acidity levels were measured at baseline and at the end of the four-week period using pH monitoring techniques. The results showed a significant decrease in stomach acidity levels in the group that received esomeprazole magnesium compared to the placebo group. This suggests that esomeprazole magnesium is effective in reducing stomach acidity in patients with GERD. Further research with a larger sample size and longer follow-up period is recommended.

Abstract 154 | pdf Downloads 51

References

1. Yang YX, Metz DC. Safety of proton pump inhibitor exposure. Gastroenterology. 2010;139(4):1115-1127.
2. Laine L, and Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol. 2012;1073):345-60.
3. Scarpignato C, Hunt RH. Proton pump inhibitors: the beginning of the end or the end of the beginning? Curr Opin Pharmacol. 2008;8(6):677-84.
4. Katelaris PH, Hungin AP, Hawkey CJ, et al. Symptom relief in endoscopy-negative GORD: where is the benefit if there is no acid. World J Gastroenterol. 2005; 11(8): 1162-1167.
5. Sachs G, Shin JM, Vagin O, et al. The gastric H,K ATPase as a drug target: past, present, and future. J Clin Gastroenterol. 2007;41:S226–S242.
6. Blanchard A, Veyrac M, Schoch H, et al. alpha-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors in the nucleus accumbens are necessary for the expression of morphine sensitization. Biol Psychiatry. 2005; 57:203-210.
7. Chey WD, Mody RR, Izat E. Patient and physician satisfaction with proton pump inhibitors (PPIs): are there opportunities for improvement? Dig Dis Sci. 2010; 55:3415-3422.
8. Fock KM, Talley N, Hunt R, et al. Report of the Asia-Pacific Consensus group on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol. 2004; 19:357–367.
9. Rainsford KD. Aspirin and the potential role of prostaglandins in colon cancer. Eur J Gastroenterol Hepatol. 2001; 13:441-449.
10. Scott LJ, Dunn CJ, Mallarkey G, Sharpe M. Esomeprazole: a review of its use in the management of acid-related disorders. Drugs 2002;62(10):1503-38.

Most read articles by the same author(s)